Vama Industries (512175)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹10.09 |
| Market Cap | ₹53.01 Cr |
| P/E Ratio | 0 |
| ROCE | 9.66% |
| ROE | 6.03% |
| Dividend Yield | 0% |
| Profit Growth | -85% |
| Debt/Equity | — |
| Sales Growth | -94.59% |
| 52-Week Range | ₹3 — ₹10.09 |
| Sector | IT - Hardware |
| Book Value | ₹2.9 |
Strengths
- ROCE at 9.66% and ROE at 6.03% are positive despite shrinking operations.
- Latest quarter net profit is ₹0 crore, not a loss, showing breakeven at a small scale.
- Stock is at the top of its 52-week range at ₹10.09, indicating some market interest.
- Small market cap of ₹53 crore keeps the absolute capital needed for revival low.
Concerns
- Sales growth is -94.59%, with latest quarterly sales of just ₹3 crore.
- Net profit of ₹0 crore and P/E of 0.00 mean no earnings support for the price.
- P/B of 3.48 against book value of ₹2.90 means paying a steep premium for a deteriorating business.
- Piotroski F-Score of 3/9 signals weak financial health, and promoter holding is undisclosed.
AI Analysis
Let me look at Vama Industries with Graham's discipline. A ₹53 crore market cap, ₹10.09 share price, and a book value of just ₹2.90 — that means I am paying 3.48 times book for a company whose sales have fallen by 94.59%. The latest quarter shows only ₹3 crore of sales and net profit of ₹0 crore. Profit growth is down 85%. This is not a business in temporary trouble; this is a business that has already lost its reason for existing. P/E shows 0.00 because earnings are effectively zero, so the price-earnings ratio cannot help me. The Piotroski F-Score of 3 out of 9 tells me the financial health is weak, and with no dividend, I get no compensation for waiting. ROE at 6.03% and ROCE at 9.66% are far below what I would demand for such risk. There is no moat, no pricing power, no growth. In computers hardware and equipment, technology shifts are brutal; this small company has no edge. I cannot value a company on hope. Buffett says it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Here I am offered a deteriorating company at an expensive price relative to book. The only thing in its favour is that the stock is at the top of its 52-week range, ₹10.09 versus a low of ₹3.00 — but market price is not value. If it traded near or below book value, with clean balance sheet and evidence of new orders, it might become a speculation worth watching. Until then, this belongs to the too-hard pile. The margin of safety is absent.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer